VOYA Investment Management
SRPT icon

VOYA Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

VOYA Investment Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$631K Buy
28,986
+425
+1% +$8.23K ﹤0.01% 1634
2025
Q4 		$615K Sell
28,561
-60,710
-68% -$1.28M ﹤0.01% 1664
2025
Q3 		$1.72M Sell
89,271
-19,575
-18% -$349K ﹤0.01% 1293
2025
Q2 		$1.86M Buy
108,846
+31,652
+41% +$1.35M ﹤0.01% 1335
2025
Q1 		$4.93M Sell
77,194
-11,162
-13% -$1.18M 0.01% 979
2024
Q4 		$10.7M Sell
88,356
-136,683
-61% -$16.8M 0.01% 729
2024
Q3 		$28.1M Sell
225,039
-97,796
-30% -$13.5M 0.03% 462
2024
Q2 		$51M Sell
322,835
-14,799
-4% -$1.9M 0.05% 327
2024
Q1 		$43.7M Buy
337,634
+35,863
+12% +$4.39M 0.04% 355
2023
Q4 		$29.1M Buy
301,771
+100,458
+50% +$9.64M 0.03% 429
2023
Q3 		$24.4M Buy
201,313
+134,579
+202% +$15.2M 0.03% 458
2023
Q2 		$7.64M Buy
66,734
+16,365
+32% +$2.11M 0.01% 829
2023
Q1 		$6.94M Sell
50,369
-8,810
-15% -$1.14M 0.01% 855
2022
Q4 		$7.67M Buy
59,179
+11,547
+24% +$1.34M 0.01% 820
2022
Q3 		$5.27M Buy
47,632
+11,945
+33% +$1.2M 0.01% 933
2022
Q2 		$2.67M Sell
35,687
-4,751
-12% -$350K 0.01% 984
2022
Q1 		$3.16M Sell
40,438
-801
-2% -$61.3K 0.01% 975
2021
Q4 		$3.71M Buy
41,239
+17,128
+71% +$1.46M 0.01% 935
2021
Q3 		$2.23M Sell
24,111
-496
-2% -$38.2K ﹤0.01% 1124
2021
Q2 		$1.91M Sell
24,607
-335
-1% -$25.4K ﹤0.01% 1227
2021
Q1 		$1.86M Sell
24,942
-1,626
-6% -$150K ﹤0.01% 1222
2020
Q4 		$4.53M Sell
26,568
-1,041
-4% -$154K 0.01% 844
2020
Q3 		$3.88M Sell
27,609
-1,110
-4% -$169K 0.01% 824
2020
Q2 		$4.61M Buy
28,719
+3,491
+14% +$475K 0.01% 778
2020
Q1 		$2.47M Sell
25,228
-976
-4% -$112K 0.01% 881
2019
Q4 		$3.38M Sell
26,204
-11,858
-31% -$1.2M 0.01% 912
2019
Q3 		$2.87M Buy
38,062
+3,553
+10% +$420K 0.01% 928
2019
Q2 		$5.24M Buy
34,509
+2,539
+8% +$309K 0.01% 789
2019
Q1 		$3.81M Sell
31,970
-7,042
-18% -$905K 0.01% 867
2018
Q4 		$4.26M Buy
39,012
+6,605
+20% +$826K 0.01% 801
2018
Q3 		$5.23M Sell
32,407
-1,500
-4% -$205K 0.01% 807
2018
Q2 		$4.48M Sell
33,907
-331,788
-91% -$31.3M 0.01% 854
2018
Q1 		$27.1M Sell
365,695
-194,179
-35% -$12.9M 0.06% 330
2017
Q4 		$31.2M Sell
559,874
-69,179
-11% -$3.66M 0.06% 301
2017
Q3 		$28.5M Buy
629,053
+60,528
+11% +$2.42M 0.06% 328
2017
Q2 		$19.2M Buy
568,525
+548,826
+2,786% +$17.9M 0.04% 407
2017
Q1 		$583K Hold
19,699
– – ﹤0.01% 1633
2016
Q4 		$540K Buy
19,699
+1,468
+8% +$59K ﹤0.01% 1691
2016
Q3 		$1.12K Hold
18,231
– – ﹤0.01% 1246
2016
Q2 		$348K Hold
18,231
– – ﹤0.01% 1936
2016
Q1 		$356K Hold
18,231
– – ﹤0.01% 1905
2015
Q4 		$703K Hold
18,231
– – ﹤0.01% 1488
2015
Q3 		$585K Sell
18,231
-3,368
-16% -$114K ﹤0.01% 1616
2015
Q2 		$657K Sell
21,599
-935
-4% -$19.1K ﹤0.01% 1729
2015
Q1 		$299K Hold
22,534
– – ﹤0.01% 2226
2014
Q4 		$326K Hold
22,534
– – ﹤0.01% 2204
2014
Q3 		$475K Hold
22,534
– – ﹤0.01% 1941
2014
Q2 		$671K Buy
22,534
+1,948
+9% +$61.6K ﹤0.01% 1772
2014
Q1 		$495K Hold
20,586
– – ﹤0.01% 1979
2013
Q4 		$419K Buy
20,586
+1,517
+8% +$45.1K ﹤0.01% 2093
2013
Q3 		$901K Hold
19,069
– – ﹤0.01% 1489
2013
Q2 		$729K Buy
+19,069
New +$682K ﹤0.01% 1569

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VOYA Investment Management's SRPT Position: Q1 2026 in Review

VOYA Investment Management increased its Sarepta Therapeutics (SRPT) stake by 1.5% in Q1 2026, buying an estimated $8.23K and bringing the position to 28,986 shares worth $631K. The position accounts for ﹤0.01% of the portfolio, ranked #1634.

VOYA Investment Management first reported a position in SRPT in Q2 2013 and has held it in 52 quarters since. The position peaked at $51M in Q2 2024. 339 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • VOYA Investment Management held 28,986 shares of Sarepta Therapeutics worth $631K as of Q1 2026.
  • VOYA Investment Management bought 425 Sarepta Therapeutics shares in Q1 2026, an estimated $8.23K.
  • Sarepta Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1634 holding.
  • VOYA Investment Management first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • VOYA Investment Management's Sarepta Therapeutics position peaked at $51M in Q2 2024.
  • 339 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.